IM8 is being hailed as the fastest-growing premium supplement brand ever recorded, reaching approximately $17 million in monthly revenue
While U.S. consumers are exposed to constant messaging about peptides, a new report reveals many are still confused about what the therapies are.
The Anthony Geisler and Gary Brecka-backed concept is seeing strong franchise demand ahead of its first openings, which are slated for the coming months.
Longevity franchise Next Health is closing in on its 20th clinic, with 26 expected by year's end and a Vancouver opening.
Solius Labs is introducing an at-home UVB medical device that tailors sunlight therapy to individual skin profiles.
Key takwaways and insights from the fitness industry's premier event.
The Portal has raised $5 million to open a 15,000-square-foot Austin club this fall, joining a wave of members-only wellness concepts.
Novo Nordisk's CEO says the company’s blockbuster obesity drugs could ultimately pull it into increasingly buzzy areas of healthcare, from longevity research to aesthetic medicine.
NewLimit has reaised $435M, led by Peter Thiel's Founders Fund, to bring an age-reversing medicine to human trial next year.
The longevity destination introduces stem cell therapies supported by an on-site stem cell bank and GMP-certified laboratory.
Sign Up to Our Newsletter
